InBody Co.,Ltd Stock Forecast for 2023 - 2025 - 2030
Updated on 05/01/2024
InBody Co.,Ltd Stock Forecast and Price Target
In recent months, notable analysts have provided yearlong price targets for InBody Co.,Ltd, with the average target coming in at ₩38000.00. If it were to be achieved, this would result in a potential upside of approximately 27.73 percent from the most recent closing price in May, 2024. The high end is ₩39000.00, and the low is ₩37000.00. If you are not interested in A041830 stock, you may be interested in its competitors.
27.73% Upside
InBody Co.,Ltd Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, InBody Co.,Ltd's Price has decreased from ₩13.10k to ₩0.00 – a 100.00% drop! Analysts predict that InBody Co.,Ltd's Fair Value will increase in the upcoming year, reaching ₩30.71k. This would represent an increase of 100.00%. Over the next seven years, experts predict that InBody Co.,Ltd's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A085370 Stock Forecast | Lutronic | - |
10
|
₩36.70k | Buy/Sell | ₩33.00k | -100.00% |
| A099190 Stock Forecast | i-SENS | Outperform |
16
|
₩19.63k | Buy/Sell | ₩32.25k | 61.74% |
| A100120 Stock Forecast | Vieworks | Outperform |
17
|
₩27.55k | Buy/Sell | ₩40.00k | 45.19% |
| A253840 Stock Forecast | Sugentech | - |
4
|
₩6.98k | Buy/Sell | ₩0.00 | -100.00% |
| A245620 Stock Forecast | Eone Diagnomics Genome Center | - |
6
|
₩400.00 | Buy/Sell | ₩0.00 | -100.00% |
InBody Co.,Ltd Revenue Forecast for 2023 - 2025 - 2030
In the last two years, InBody Co.,Ltd's Revenue has seen an increase, rising from ₩107.12B to ₩160.00B. This represents a growth of 49.37%. Analysts predict that InBody Co.,Ltd's Revenue will increase in the upcoming year, reaching ₩200.15B. This would represent an increase of 25.09%. Over the next seven years, experts predict that InBody Co.,Ltd's Revenue will grow at a rate of 24.18%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A150840 Stock Forecast | IntroMedic | - |
6
|
₩5.85k | Buy/Sell | ₩0.00 | -100.00% |
| A156100 Stock Forecast | L&K Biomed |
4
|
₩8.64k | Buy/Sell | ₩14.50k | -100.00% | |
| A208370 Stock Forecast | SELVAS Healthcare |
0
|
₩4.77k | Buy/Sell | ₩0.00 | -100.00% |
.jpg)
InBody Co.,Ltd Dividend per Share Forecast for 2023 - 2025 - 2030
InBody Co.,Ltd's Dividend per Share has seen growth In the last two years, going from ₩140.00 to ₩300.00 – a gain of 114.29% In the next year, analysts believe that Dividend per Share will reach ₩450.00 – an increase of 50.00%. For the next seven years, the forecast is forDividend per Share to grow by 37.30%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A058110 Stock Forecast | MEKICS CO., Ltd | - |
8
|
₩3.25k | Buy/Sell | ₩0.00 | -100.00% |
| A122310 Stock Forecast | Genoray | - |
18
|
₩6.90k | Buy/Sell | ₩0.00 | -100.00% |
| A041920 Stock Forecast | MEDIANA Co.,Ltd | - |
14
|
₩6.18k | Buy/Sell | ₩16.18k | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A263690 Stock Forecast | DRGEM | - |
16
|
₩10.22k | Buy/Sell | ₩0.00 | -100.00% |
| A214680 Stock Forecast | DRTECH | - |
0
|
₩4.16k | Buy/Sell | ₩0.00 | -100.00% |
| A149980 Stock Forecast | Hironic | - |
13
|
₩9.96k | Buy/Sell | ₩0.00 | -100.00% |
InBody Co.,Ltd EBITDA Forecast for 2023 - 2025 - 2030
InBody Co.,Ltd's EBITDA has grown in the last two years, jumping from ₩23.52B to ₩46.08B – an increase of 95.92%. In the next year, analysts predict that EBITDA will reach ₩56.65B – an increase of 22.94%. For the next seven years, the forecast is for EBITDA to grow by 24.05%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A302550 Stock Forecast | Remed | - |
10
|
₩2.87k | Buy/Sell | ₩8.40k | -100.00% |
| A115480 Stock Forecast | CU Medical Systems | - |
0
|
₩827.00 | Buy/Sell | ₩0.00 | -100.00% |
| A290660 Stock Forecast | Neofect Co.,Ltd | - |
0
|
₩1.18k | Buy/Sell | ₩0.00 | -100.00% |
InBody Co.,Ltd EBIT Forecast for 2023 - 2025 - 2030
In the last two years, InBody Co.,Ltd's EBIT has increased by 114.09%, going from ₩19.01B to ₩40.70B. In the next year, analysts are expecting an increase in EBIT, predicting it will reach ₩50.20B – an increase of 23.33%. The InBody Co.,Ltd forecast is for EBIT to reach ₩51.10B or grow by 25.53%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| A258830 Stock Forecast | Sejong Medical | - |
12
|
₩412.00 | Buy/Sell | ₩0.00 | -100.00% |
| A031860 Stock Forecast | SU-Holdings | - |
4
|
₩1.60k | Buy/Sell | ₩0.00 | -100.00% |
| A219750 Stock Forecast | GTG Wellness | - |
0
|
₩2.85k | Buy/Sell | ₩20.00k | -100.00% |
InBody Co.,Ltd EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, InBody Co.,Ltd's EPS has decreased from ₩1335.00 to ₩0.00 – a 100.00% drop! Analysts predict that InBody Co.,Ltd's EPS will increase in the upcoming year, reaching ₩3130.50. This would represent an increase of 100.00%. Over the next seven years, experts predict that InBody Co.,Ltd's EPS will grow at a rate of 100.00%.
.jpg)